This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (51)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Raymond C. Read, MD, PhD; Robert Schaefer, MD; Neshe North; Robert Walls, PhD

Arch Surg. 1988;123(4):446-449.

Abstract
• We analyzed 384 veterans who had "curative" (sometimes conservative) resection from 1966 through 1986 for stage I, non—small-cell primary lung cancer to identify significant variables influencing survival. Operative mortality was 3.1%, mainly from heart attacks. Most patients were asymptomatic, presenting with other diseases of smoking. Five-year survival was 43%; deaths from lung cancer only, 63% (T1,73%; T2,49%). Two hundred fourteen (57.5%) of the 372 operative survivors had T1 and 158 (42.5%) had T2 disease. Sixty-five percent had peripheral nodules (84%, T1; 38% T2). Pure squamous cell predominated, in 63% overall (T1, 55%; T2, 74%). Systemic metastases caused most cancer deaths. Within T1, diameter was highly significant. Cell type and time of operation (before or after Dec 31, 1980) were also significant. Under T2, only scarring and differentiation were significant. Veterans in this group live longer if they have small squamous cell tumors.

(Arch Surg 1988;123:446-449)

Author Affiliations
From the Veterans Administration Medical Center and the University of Arkansas for Medical Sciences, Little Rock.

Footnotes
Accepted for publication Sept 25, 1987.

Read before the Association of Veterans Administration Surgeons, Portland, Ore, May 7, 1987.

Reprint requests to Surgical Service, Veterans Administration Medical Center, 4300 W 7th St, Little Rock, AR 77201 (Dr Read).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Critical Points When Using Vectors
Detterbeck
JCO 2009;27:e166-e166.
FULL TEXT  

Reply to F.C. Detterbeck
Rong and Zhu
JCO 2009;27:e167-e167.
FULL TEXT  

Clinical experience with radiotracer-guided thoracoscopic biopsy of small, indeterminate lung nodules.
Stiles et al.
Ann. Thorac. Surg. 2006;82:1191-1197.
ABSTRACT | FULL TEXT  

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
Belinsky et al.
Cancer Res. 2006;66:3338-3344.
ABSTRACT | FULL TEXT  

Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk
Belinsky et al.
Clin. Cancer Res. 2005;11:6505-6511.
ABSTRACT | FULL TEXT  

Survival After Pathological Stage IA Nonsmall Cell Lung Cancer: Tumor Size Matters
Birim et al.
Ann. Thorac. Surg. 2005;79:1137-1141.
ABSTRACT | FULL TEXT  

Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control
Wu et al.
Eur. J. Cardiothorac. Surg. 2003;24:994-1001.
ABSTRACT | FULL TEXT  

Disparities in surgical resection of early-stage non-small cell lung cancer
Jazieh et al.
J. Thorac. Cardiovasc. Surg. 2002;123:1173-1176.
ABSTRACT | FULL TEXT  

Quantification of Ground-Glass Opacity on High-Resolution CT of Small Peripheral Adenocarcinoma of the Lung: Pathologic and Prognostic Implications
Kim et al.
Am. J. Roentgenol. 2001;177:1417-1422.
ABSTRACT | FULL TEXT  

Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
Jazieh et al.
Ann. Thorac. Surg. 2000;70:1168-1171.
ABSTRACT | FULL TEXT  

Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung Cancer
Patz et al.
Chest 2000;117:1568-1571.
ABSTRACT | FULL TEXT  

Sex-associated differences in survival of patients undergoing resection for lung cancer
Ferguson et al.
Ann. Thorac. Surg. 2000;69:245-249.
ABSTRACT | FULL TEXT  

Smoking Before Surgery Predicts Poor Long-Term Survival in Patients With Stage I Non-Small-Cell Lung Carcinomas
Fujisawa et al.
JCO 1999;17:2086-2086.
ABSTRACT | FULL TEXT  

Follow-up in Lung Cancer: How Often and for What Purpose?
Younes et al.
Chest 1999;115:1494-1499.
ABSTRACT | FULL TEXT  

Surgical Results and Prognostic Factors in Early Non-Small Cell Lung Cancer
Padilla et al.
Ann. Thorac. Surg. 1997;63:324-326.
ABSTRACT | FULL TEXT  

Survival in Early-Stage Non--Small Cell Lung Cancer
Nesbitt et al.
Ann. Thorac. Surg. 1995;60:466-472.
ABSTRACT | FULL TEXT  

Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma:Five-year survival and patterns of intrathoracic recurrence
Warren and Faber
J. Thorac. Cardiovasc. Surg. 1994;107:1087-1094.
ABSTRACT | FULL TEXT